42,443 Shares in Core Laboratories Inc. $CLB Bought by Pacific Ridge Capital Partners LLC

Pacific Ridge Capital Partners LLC purchased a new stake in shares of Core Laboratories Inc. (NYSE:CLB) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 42,443 shares of the oil and gas company’s stock, valued at approximately $525,000. Pacific Ridge Capital Partners LLC owned 0.09% of Core Laboratories at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CLB. Illinois Municipal Retirement Fund raised its holdings in shares of Core Laboratories by 4.0% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 23,366 shares of the oil and gas company’s stock worth $289,000 after purchasing an additional 898 shares during the period. Advisors Capital Management LLC increased its position in Core Laboratories by 0.3% during the 3rd quarter. Advisors Capital Management LLC now owns 275,975 shares of the oil and gas company’s stock worth $3,411,000 after purchasing an additional 912 shares in the last quarter. Fox Run Management L.L.C. raised its holdings in Core Laboratories by 5.9% in the third quarter. Fox Run Management L.L.C. now owns 18,531 shares of the oil and gas company’s stock valued at $229,000 after buying an additional 1,038 shares during the period. The Manufacturers Life Insurance Company lifted its position in Core Laboratories by 6.2% during the second quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock valued at $207,000 after buying an additional 1,040 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Core Laboratories by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock worth $418,000 after buying an additional 1,170 shares during the period. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Core Laboratories Stock Down 0.3%

Shares of NYSE:CLB opened at $17.52 on Thursday. The company has a market capitalization of $815.50 million, a price-to-earnings ratio of 26.14, a price-to-earnings-growth ratio of 15.33 and a beta of 1.09. The company has a 50 day moving average of $18.28 and a two-hundred day moving average of $15.16. Core Laboratories Inc. has a 52-week low of $9.72 and a 52-week high of $20.36. The company has a quick ratio of 1.57, a current ratio of 2.07 and a debt-to-equity ratio of 0.39.

Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.01. The business had revenue of $138.26 million during the quarter, compared to the consensus estimate of $130.40 million. Core Laboratories had a net margin of 6.04% and a return on equity of 12.09%. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.22 earnings per share. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. As a group, analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 9th. Stockholders of record on Monday, February 16th will be given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, February 13th. Core Laboratories’s payout ratio is presently 5.97%.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Core Laboratories in a research note on Monday, December 29th. Four equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $12.50.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.